Melatonin Inhibits Hypoxia-Induced Alzheimer’s Disease Pathogenesis by Regulating the Amyloidogenic Pathway in Human Neuroblastoma Cells
Open Access
- 10 May 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (10) , 5225
Abstract
Stroke and Alzheimer’s disease (AD) are prevalent age-related diseases; however, the relationship between these two diseases remains unclear. In this study, we aimed to investigate the ability of melatonin, a hormone produced by the pineal gland, to alleviate the effects of ischemic stroke leading to AD by observing the pathogenesis of AD hallmarks. We utilized SH-SY5Y cells under the conditions of oxygen–glucose deprivation (OGD) and oxygen-glucose deprivation and reoxygenation (OGD/R) to establish ischemic stroke conditions. We detected that hypoxia-inducible factor-1α (HIF-1α), an indicator of ischemic stroke, was highly upregulated at both the protein and mRNA levels under OGD conditions. Melatonin significantly downregulated both HIF-1α mRNA and protein expression under OGD/R conditions. We detected the upregulation of β-site APP-cleaving enzyme 1 (BACE1) mRNA and protein expression under both OGD and OGD/R conditions, while 10 µM of melatonin attenuated these effects and inhibited beta amyloid (Aβ) production. Furthermore, we demonstrated that OGD/R conditions were able to activate the BACE1 promoter, while melatonin inhibited this effect. The present results indicate that melatonin has a significant impact on preventing the aberrant development of ischemic stroke, which can lead to the development of AD, providing new insight into the prevention of AD and potential stroke treatments.Keywords
Funding Information
- Chulabhorn Graduate Institute, Chulabhorn Royal Academy (651-AB01)
This publication has 72 references indexed in Scilit:
- Melatonin improves cognitive function by suppressing endoplasmic reticulum stress and promoting synaptic plasticity during chronic cerebral hypoperfusion in ratsBiochemical Pharmacology, 2022
- Ischemic StrokeThe American Journal of Medicine, 2021
- Stroke in the Young: a Global UpdateCurrent Neurology and Neuroscience Reports, 2019
- Expression of the Tau Protein and Amyloid Protein Precursor Processing Genes in the CA3 Area of the Hippocampus in the Ischemic Model of Alzheimer’s Disease in the RatMolecular Neurobiology, 2019
- BACE1 inhibition more effectively suppresses initiation than progression of β-amyloid pathologyActa Neuropathologica, 2018
- Dementia and death after stroke in older adults during a 10-year follow-up: Results from a competing risk modelThe Journal of nutrition, health and aging, 2017
- HIF‐1 at the crossroads of hypoxia, inflammation, and cancerInternational Journal of Cancer, 2015
- Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: Implications for early intervention and therapeuticsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Nuclear translocation of hypoxia-inducible factors (HIFs): Involvement of the classical importin α/β pathwayBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2008
- Intermittent hypoxia changes HIF-1α phosphorylation pattern in endothelial cells: Unravelling of a new PKA-dependent regulation of HIF-1αBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007